Clinical Science

Papers
(The H4-Index of Clinical Science is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Retraction: BMSC-derived exosomes carrying microRNA-122-5p promote progression of osteoblasts in osteonecrosis of the femoral head183
Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats166
Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy166
Aging and sex differences in salt sensitivity of blood pressure158
Cancer therapy-related cardiac dysfunction: is endothelial dysfunction at the heart of the matter?147
Novel avenues to control blood pressure: targeting the renal lymphatic system132
The double sides of NLRP3 inflammasome activation in sepsis106
Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms104
The importance of placental lipid metabolism across gestation in obese and non-obese pregnancies72
Interactions between cardiology and oncology drugs in precision cardio-oncology68
Measuring muscle protein synthesis in humans and the influence of nutritional state62
Increased angiotensin II formation in the brain modulates cardiovascular homeostasis and erythropoiesis51
Sex differences in angiotensin II-induced hypertension and kidney injury: role of AT1a receptors in the proximal tubule of the kidney49
Arrb2 causes hepatic lipid metabolism disorder via AMPK pathway based on metabolomics in alcoholic fatty liver47
Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability46
The science of science: Clinical Science launches a new translational meta-research collection46
G-protein-coupled receptor kinase 4 causes renal angiotensin II type 2 receptor dysfunction by increasing its phosphorylation44
Visualization of regenerating and repairing hearts44
Diminished Rbfox1 increases vascular constriction by dynamically regulating alternative splicing of CaV1.2 calcium channel in hypertension39
Extracellular vesicle-mediated targeting strategies for long-term health benefits in gestational diabetes38
Regulation of Na+-K+-ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca2+-dependent cardiac metabolism38
PE (0:0/14:0), an endogenous metabolite of the gut microbiota, exerts protective effects against sepsis-induced intestinal injury by modulating the AHR/CYP1A1 pathway38
miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction37
Physiological response to fetal intravenous lipid emulsion35
Maintaining energy provision in the heart: the creatine kinase system in ischaemia–reperfusion injury and chronic heart failure35
Importance of the gut microbiota in mice with a ‘humanized’ bile acid pool34
Is endothelin targeting finally ready for prime time?33
PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer33
New discoveries in bile acids, gut microbiota and host interactions in health and diseases32
Endothelin-1 down-regulates nuclear factor erythroid 2-related factor-2 and contributes to perivascular adipose tissue dysfunction in obesity32
Paradoxical effects of osteoprotegerin on vascular function: inhibiting inflammation while promoting oxidative stress?32
CXCL5 inhibition ameliorates acute kidney injury and prevents the progression from acute kidney injury to chronic kidney disease32
0.19093894958496